Free tool
FAERS Monitor: Medical Air, Usp
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 205890 or its brand name (Medical Air, Usp, Medical Air). Reports on generic versions are filed under their own applications.
Reports
18
Serious
16
89% of reports
Hospitalization
4
Death reported
1
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug interaction3
- atrial fibrillation2
- blood pressure decreased2
- cardiac arrest2
- cyanosis2
- dystonia2
- oxygen saturation decreased2
- polyuria2
- sinus tachycardia2
- acidosis1
- alanine aminotransferase increased1
- anaesthetic complication cardiac1
- aneurysm ruptured1
- arrhythmia1
- aspartate aminotransferase increased1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2021 | 3 |
| 2023 | 2 |
| 2026 | 1 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,141 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| anaesthetic complication cardiac | 1 | 17201.1 | 2522.9 | 4,237 |
| aneurysm ruptured | 1 | 1276.9 | 189.9 | 318 |
| polyuria | 2 | 285.5 | 77.3 | 318 |
| sinus tachycardia | 2 | 164.7 | 44.6 | 182 |
| acidosis | 1 | 152.9 | 22.8 | 37 |
| cyanosis | 2 | 148.6 | 40.2 | 164 |
| dystonia | 2 | 120.5 | 32.6 | 133 |
| oxygen saturation decreased | 2 | 41.6 | 11.3 | 44 |
| blood pressure decreased | 2 | 35.2 | 9.5 | 37 |
| cardiac arrest | 2 | 28.3 | 7.7 | 29 |
| arrhythmia | 1 | 24.7 | 3.7 | 5 |
| atrial fibrillation | 2 | 24.0 | 6.5 | 24 |
| drug interactionSignal | 3 | 22.1 | 7.9 | 41 |
| aspartate aminotransferase increased | 1 | 22.0 | 3.3 | 5 |
| alanine aminotransferase increased | 1 | 19.0 | 2.8 | 4 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.